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For most central nervous system neurons, emigration 
from the ventricular zone marks their entrance into a 
state from which they will never normally re-enter a cell 
cycle. Th  e prohibition against cell division in this new 
state of existence is suﬃ   ciently strong that if a neuron 
does try to divide then it will die.
Th  e molecular mechanisms that link cell cycle to cell 
death in this situation are not fully understood, but the 
relationship is completely straightforward in young post-
mitotic neurons. As documented in several laboratories, 
if a neuron is forced to divide by expression of an 
oncogene, it will re-enter a cycle and die. If any of several 
cell cycle suppressor functions are lost, the neuron will 
re-enter a cycle and die. If a cultured neuron is exposed 
to oxidative stress, DNA damaging agents or certain 
neuro  toxins (including Aβ aggregates), it will re-enter a 
cycle and die. Th   e cell cycle events are directly involved 
in the mechanics of cell death. We know this because if 
progression through the cycle is blocked, cell cycle-
related neuronal death (CRND) is also blocked. Finally, 
the developing nervous system itself makes use of 
CRND during the process of numerical matching. 
Hours before they die, target-deprived neurons re-
express cell cycle proteins and engage in a new round of 
DNA synthesis [1-6].
Th   ese data lend themselves to a simple linear model of 
neuronal death as illustrated in Figure 1. Th   e relevance of 
this model to Alzheimer’s disease (AD) is high, under-
scored by an entire body of evidence that a CRND-like 
process occurs in the populations of neurons that are lost 
during the disease – hippocampal formation, frontal 
cortex, basal nucleus, dorsal raphe and locus coeruleus. 
In autopsy samples, neuronal cell cycle events are clearly 
present, detected primarily as re-expression of immuno-
reactive proteins normally found only in dividing cells. 
Beyond the immunocytochemical evidence, several 
labora  tories have used cytogenetic techniques to show 
that the chromosome copy number increases. Th  is  means 
that CRND involves true DNA replication, as distinct 
from DNA repair.
Th  e use of human autopsy samples places limits on 
researchers’ ability to fully test the cell cycle model in AD, 
but several qualitative features of the observed neuronal 
cell cycle activity ﬁ  t well with the model outlined above. 
First, every population of neuron that is lost during AD 
has neurons that stain positive for cell cycle proteins. 
Second, neuronal populations that are spared in AD are 
negative for cell cycle activity. Th   ird, cell cycle events have 
been reported in subjects whose death occurred when a 
mild cognitive impairment had only recently been detected 
[7]. Th   is is evidence that the cell cycle events are linked to 
neuronal cell death at all stages of the disease and do not 
occur only as co-morbid problems unique to the ﬁ  nal 
stages of the disease process. Fourth, neurons in age-
matched controls have, on average, an order of magnitude 
fewer cell cycle-positive neurons. Fifth, in mouse models 
of AD, cell cycle events accurately recapitulate both the 
spatial and temporal progression of neuronal loss seen in 
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Most neurons undergo their last cell division within 
the fi  rst 1 to 2% of the lifespan of an organism. This 
has been interpreted to mean that adult neurons are 
permanently postmitotic, but Alzheimer’s disease 
(AD) is an example of a late-onset neurodegenerative 
disease that challenges this concept. In AD, neurons in 
populations at risk for death reactivate their cell cycle 
and replicate their genome – but rather than complete 
the cycle with mitosis and cytokinesis, the neurons die. 
While opening new perspectives on the etiology of AD 
dementia, the simple linear model suggested by this 
description gains in complexity with the maturation 
of the adult brain. This complexity makes the full 
understanding of the relationship between cell division 
and cell death more diffi   cult to achieve. The quest 
for understanding is worthwhile, however, as fresh 
avenues for therapeutic intervention are the prizes for 
success.
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© 2010 BioMed Central Ltdhuman AD. Finally, the linkage of neurodegeneration to 
ectopic cell cycle reactivation has been documented in 
diseases apart from AD – such as ataxia–telangiectasia, 
Parkinson’s disease, stroke, amyotrophic lateral sclerosis, 
and others.
Th   e strength of this evidence notwithstanding, caution 
is still advised before applying a simple linear cell cycle 
model to explain the death of neurons in AD. Viewed 
objectively, the human data are purely correlative. 
Rigorous proof of causality (cell cycle  cell death) is still 
missing, and we should therefore move slowly in applying 
the complete embryonic model to the neurons of the 
adult brain.
To completely establish the mechanistic role of cell 
cycle events in AD, two important pieces of data are 
needed. Th  e  ﬁ  rst is proof that it is the cycling cells which 
die. We believe this is true and the experimental data 
from the embryonic neurons suggest this belief is well 
founded. But the available evidence does not allow us to 
disprove the alternative that, in the adult brain, cell cycle 
re-entrance is protective rather than destructive. Th  e 
second piece of data needed to establish causality is to 
show that if we block the cell cycle in AD neurons then 
we can block their death. Th  is will be an exceedingly 
diﬃ   cult proof to obtain, but a positive outcome would 
open a fresh approach to disease prevention. Th   e task is 
therefore worth engaging.
In this vein, an encouraging result has recently been 
reported in experiments designed to measure the eﬀ  ects 
of chronic nonsteroidal anti-inﬂ  ammatory drug (NSAID)   
administration on the appearance of cell cycle events in 
an APP transgenic mouse line [8]. In untreated transgenic 
mice, evidence of neuronal cell cycling occurs in a 
temporal and spatial pattern that mimics the 
neurodegeneration found in AD. When either ibuprofen 
or naproxen is administered before the cycles begin, 
however, the appearance of these cell cycle events is 
blocked. Th  is is reminiscent of reports from human 
epidemiological studies citing the reduced risk of AD in 
individuals with a history of long-term use of certain 
NSAIDs [9].
A major unanswered question, given the mouse data, is 
why prospective NSAID clinical trials in humans have all 
ended with no evidence of signiﬁ  cant  eﬀ   ect on AD 
symptoms. It may be hoped that the discrepancy is 
explained by the fact that the mouse studies and the 
epidemiology measure prevention (drug administration 
is initiated before the cell cycle events began) while the 
clinical trials measure therapeutic potential (drug 
treatment begins after the subjects have been identiﬁ  ed 
as having disease). Evidence in support of this idea comes 
from the mouse studies themselves [8]. When drug 
administration was delayed until later in the disease 
process, NSAID treatment was found not to reverse the 
cell cycle events in neurons in which disease had begun. 
While specu  la  tive, this explanation should keep alive the 
hope that NSAIDs may yet point the way to eﬀ  ective 
disease deterrents in humans – even if curative therapies 
will require other strategies.
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Figure 1. Simple linear model of neuronal death. A simple linear 
pathway connecting stress transduced through an increase in the 
probability of entering a cell cycle to DNA replication and, in the 
embryo, directly to neuronal death. In the mature adult neuron, the 
linkage to cell death is interrupted (question marks) and the cell 
can maintain a hyperploid genetic content and survive for months 
if not years.
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